Skip to main content
Erschienen in: Globalization and Health 1/2014

Open Access 01.12.2014 | Review

Globalization of leptospirosis through travel and migration

Erschienen in: Globalization and Health | Ausgabe 1/2014

Abstract

Leptospirosis remains the most widespread zoonotic disease in the world, commonly found in tropical or temperate climates. While previous studies have offered insight into intra-national and intra-regional transmission, few have analyzed transmission across international borders. Our review aimed at examining the impact of human travel and migration on the re-emergence of Leptospirosis. Results suggest that alongside regional environmental and occupational exposure, international travel now constitute a major independent risk factor for disease acquisition. Contribution of travel associated leptospirosis to total caseload is as high as 41.7% in some countries. In countries where longitudinal data is available, a clear increase of proportion of travel-associated leptospirosis over the time is noted. Reporting patterns is clearly showing a gross underestimation of this disease due to lack of diagnostic facilities. The rise in global travel and eco-tourism has led to dramatic changes in the epidemiology of Leptospirosis. We explore the obstacles to prevention, screening and diagnosis of Leptopirosis in health systems of endemic countries and of the returning migrant or traveler. We highlight the need for developing guidelines and preventive strategies of Leptospirosis related to travel and migration, including enhancing awareness of the disease among health professionals in high-income countries.
Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​s12992-014-0061-0) contains supplementary material, which is available to authorized users.

Competing interests

All authors declare (1) no support from any organization for the submitted work; (2) no financial relationships with any organizations that might have an interest in the submitted work in the previous three years; and (3) no other relationships or activities that could appear to have influenced the submitted work.

Authors’ contribution

MB and MA carried out the literature search, data extraction and table preparation. MB and EB analyzed and interpreted data and prepared the draft manuscript. EB completed the manuscript writing. KW and SA conceived the study, design the methodology, revised the final manuscript and coordinated the review process. All authors read and approved the final manuscript.

Introduction

Leptospirosis has traditionally been described in the medical literature as a treatable zoonotic disease endemic to low-income countries in temperate and tropical regions [1]. As a clinical entity it is strongly associated with regional occupational and environmental exposures [2]. WHO Leptospirosis Burden Epidemiology Reference Group (LERG) estimates [3], 873,000 annual cases and 48,000 deaths due to leptospirosis [4]. The countries with the highest reported incidence are located in the Asia-Pacific region (Seychelles, India, Sri Lanka and Thailand) with incidence rates over 10 per 1000,000 people s well as in Latin America and the Caribbean (Trinidad and Tobago, Barbados, Jamaica, El Salvador, Uruguay, Cuba, Nicaragua and Costa Rica) [5].
In recent years however, recreational exposure to water has emerged as a strong risk-factor for disease transmission [6]. Over the past twenty years, leptospirosis cases diagnosed among international travelers have become increasingly common [7] and the disease is now emerging as a major public health concern worldwide [5]. Both neglected and under-reported, there is scant epidemiological data on leptospirosis therefore masking the true scope of disease prevalence and making reliable morbidity and mortality statistics difficult to ascertain [3]. Chronic underreporting of leptospirosis is due in large part to clinical misdiagnosis [8]. Patients present with clinical signs difficult to distinguish from other endemic illnesses including dengue fever, malaria, HIV, rickettsial disease and yellow fever. Further, regional and district level health centers often lack appropriate diagnostic laboratories to perform the serological testing required to establish a diagnosis [9].
To date, studies investigating leptospirosis have described high disease prevalence among economically marginalized populations in endemic regions. Urban slums [10]-[15] lacking access to adequate sewage disposal and water treatment infrastructure as well as rural farming communities working in rice [16]-[20] or sugar cane fields [21]-[23] have been highlighted as communities facing the highest risk. These populations are particularly vulnerable to seasonal monsoons and flooding which can heighten the risk of transmission and lead to outbreaks and possible epidemics. Additionally, high-risk occupational groups for the disease include fishermen [24], sewer workers [25], dairy industry workers [26], veterinarians [27], miners [28] and military personnel [29]-[32]. In countries where disease is regionally endemic, internal migration patterns and exposures are crucial risk factors for the spread of the disease.
The rise in global travel and eco-tourism [33] has led to dramatic changes in the epidemiology of leptospirosis. Despite decreasing prevalence of leptospirosis in endemic regions, previously non-endemic countries are now reporting increasing numbers of cases due to recreational exposure [34]. International travelers engaged in adventure sports are directly exposed to numerous infectious agents in the environment and now comprise a growing proportion of cases worldwide. Similarly, in recent years outdoor athletic events have been linked with several outbreaks among foreign travelers.
To date, the global impact of international travel and migration as a major determinant of leptospirosis transmission has yet to be thoroughly analyzed in the medical literature. In this paper we aim to evaluate the impact of human migration and recreational travel on the re-emergence of leptospirosis.

Methods

Search strategy

We conducted a comprehensive review of existing leptospirosis literature via online databases. Our principle aim was to identify all studies published in peer-reviewed journals and indexed in PubMed that explored the association between human migration and leptospirosis published through March 2013. Although non-English studies were excluded, we extracted data from studies that had English abstracts. To identify relevant articles not found in PubMed, we supplemented the search strategy by first searching the indices of several journals manually: Travel Medicine and Infectious Disease, Journal of Travel Medicine, International Medical Travel Journal, International Journal of Travel Medicine and Global Health, and second by reviewing reference lists of primary studies.

Inclusion criteria and definitions

Studies that reported confirmed and probable cases of leptospirosis were deemed eligible for inclusion. Reviewers screened citations by reviewing titles and abstracts to identify potentially relevant studies. Disagreements between the reviewers were resolved by consensus. The database was then screened a second time using more focused inclusion criteria to isolate only primary articles. Subsequently the full text of each citation was obtained and reviewed. In cases where full articles could not be obtained, the article abstract was used. We adopted the case-definition of leptospirosis based on the guidelines from the LERG [35] to include studies in the review. No restrictions were made with regard to the outcome variables as this was a review of observational studies.

Data extraction

A data collection form was prepared and pilot tested prior to data extraction activities begun. In order to minimize biases in data extraction, the methods of selected studies were reviewed in detail by two independent reviewers under the supervision of the principle investigator. Subgroup analyses were done to minimize heterogeneity across studies. Data were pooled only when studies were reasonably consistent in their methods. Variables were examined in detail, including: number of cases, country of residence, exposure country/region, proportion of travel related cases, type and nature of study (population based vs. hospital based cohort), type of exposure, time period and year.

Results

Of the 10,289 articles we identified on leptospirosis, only 141 met the key-word criteria related to travel/migration. We identified a total of 149 potentially relevant citations from both the PubMed and cumulative literature search once duplicate references were removed. These were further reduced to 60 after undertaking a title and abstract review. Following an in-depth review of the full-texts of these papers 48 were included for final analysis (Figure 1).
Of the 54 publications, 33 reported individual travel reported leptospirosis cases or case reports, nine reported cases by country and/or regional caseload and six reported cases in the context of travel related fever. After the full text review 12 articles were excluded from final qualitative analysis. We excluded a case acquired due to an imported animal, five reports without primary data and six reviews from the final qualitative data analysis. All studies we encountered clearly identified the geographical region where disease was acquired.
Data extraction was completed for 3 distinct subgroups:
1.
Papers citing travel as a significant contributory factor to overall country level leptospirosis case loads (9 studies)
 
2.
Those that highlighted the contribution of leptospirosis to larger trends in travel associated fever (5 studies); and
 
3.
Case reports and case series illustrating travel-associated leptospirosis (33 studies)
 
The nine studies reporting cases of leptospirosis among travellers or migrants as a proportion of the general population contained data of 6 countries: The Netherlands [36],[37], Israel [38], Germany [39],[40], Austria [39], Japan [41],[42], Thailand [43] and the USA [44] (Table 1), all of which are high-income nations with the exception of Thailand. In the USA, country level data was not available, but complete data set for Hawaii was available only up through 2008.
Table 1
Country level data and proportion of travel related leptospirosis
Reference
Country
Period of study
Total cases
Travel associated cases
Country of exposure
Type of exposure
Positive test that was diagnostic of leptospirosis
Goris, Kimberly et al., [36]
Netherlands
1925 - 2008
2553
318(12.5%)
Europe – 132
Recreational- 257,
Culture/MAT
Asia – 134
South America – 25
Job-related 21,
Central and North
America – 13
Accidental 22,
Sub-Saharan Africa – 7
Middle East – 2
Australia – 1
Leshem et al., [38]
Israel
2002-2008
48
20(41.7%)
Southeast Asia - 15,
Participation in water related activities
Not mentioned
Africa - 2,
Oceania - 2, Central
America - 1
Hoffmeister et al., [39]
Germany and Austria
1998-2008
59
24(40.7%)
Caribbean - 10,
Recreational
ELISA, MAT, PCR
Asia - 9, Eastern Europe - 3, Central America - 1,
South America - 1
Taniguchi et al., [42]
Japan
1999-2008
95
7(7.4%)
Not mentioned
Not mentioned
Not mentioned
Jansen et al., [40]
Germany
1997-2003
248
39(15.7%)
France - 4,
Not mentioned
Not mentioned
Greece - 2,
Poland - 2,
Hungary - 2,
Norway-1,
Croatia-1,
Bulgaria-1
Narita et al., [41]
Japan
1999
14
9(62.3%)
 
Exposure to contaminated soil or water
Not mentioned
Ariyapruchya et al., [43]
Thailand
1994 - 2000
59
10(16.9%)
Northeastern part of Thailand
  
Katz et al., [44]
USA
1974 - 1998
752
43(5.7%)
43 - outside the state
  
27 - Federated States of Micronesia,
6 -American Samoa,
4 - Guam,
from Costa Rica-2
Thailand-1,
Philippines-1
Mexico-1
Utah-1
Crevel et al., [37]
Netherlands
1987 - 1991
237
32(13.5%)
Thailand -24
Contact with freshwater,
MAT,ELISA
Other Southeast Asian countries-4,
21- water-rafting in Thailand
Ivory Coast-1,
Surinam-3
Among reports of systematically collected country level data, Israel reported the highest incidence of travel associated leptospirosis (41.7%). In Germany, before 2003 this contribution was only 15.7%. However, a later study showed that the travel related cases increased up to 40.7% in 2008. Netherland has the largest reported database describing travel associated leptospirosis which included 318 cases out of 2553 cases related to international travel. In Germany and Netherlands, intra-country travel comprised over 40% of the disease burden. One study conducted in Germany using aggregate data from 1962–2002 found that 13 out of 39 travel related leptospirosis cases were acquired from European countries where leptospirosis is rare, with the majority of these cases occurring between 1960 and 1980. The study results suggest that in the last two decades, this trend has shifted, with Latin America and Caribbean Islands serving as the main geographical location for disease transmission and infection among German nationals. Data from Japan reports that around 7% are none residents thus travel related. Data from Hawaii shows that 5.7% of leptospirosis cases reported in Hawaii were from mainland USA and 23% from smaller islands. Other than Hawaii islands where Leptospirosis is endemic and disease transmission was within the state, the major contribution to travel related leptospirosis was from southeast Asia/Asia.
Contribution of leptospirosis to travel associated fever was reported among more than 7000 febrile cases in six studies (Table 2). All studies were from developed countries. Leptospirosis was responsible for 0.21% to 2.65% of all travel associated fever cases. Among Western travelers, which included travelers from North America, Europe, Israel, Japan, Australia and New Zealand, leptospirosis contributed to 2.65% of all travel related febrile illnesses [45]. Individual reports from Sweden [46], Australia [47] and Finland [48] and combined reports by Flores-Figueroa et al. [49] and Field et al. [50] showed less than 1% contribution. South East Asia was reported as the main exposure area.
Table 2
Leptospirosis cases detected out of travelers presenting with fever
Reference
Country
Period of study
Total cases
Total fever cases
Country of exposure
Type of travel
Jensenius et al., [45]
North America, Europe, Israel, Japan, Australia, New Zealand
1996 – 2011
88(2.65%)
3326
Caribbean - 7, Central America - 15, North Africa - 3, Oceania - 2, South America - 4, South Central Asia - 3, Southeast Asia - 49 (Thailand - 19, Laos - 11), Sub-Saharan Africa - 5
Tourists-82% Others; on business and visiting friends and relatives
Flores-Figueroa et al., [49]
Canada - 1
1996-2010
6(0.75%)
804
Costa Rica, Mexico, Panama
Tourist, missionary and business
USA – 4
France - 1
Siikamaki et al., [48]
Finland (Helsinki)
2005 – 2009
1(0.21%)
 
Asia
 Unknown
Field et al., [50]
Europe
2008
7(0.50%)
1378
Cambodia-2, Cameroon-1, Central African Republic-1, Costa Rica-1, Indonesia-1, Reunion-1
Unknown
Askling et al., [46]
Sweden
2005-2008
7(0.50%)
1432
Tropical countries - Africa, Asia, America
Unknown
Goldsmid et al., [47]
Australia (Tasmania)
 
1
NR
India
Studies (river)
Of the 27 case reports and 6 case series, 3 reported on leptospirosis due local travel within the country. Two of these studies examined transmission from the continental US to Hawaii [51],[52] and from the Jordan River Valley in Israel to the northern part of the country [32]. All other case reports were focused on infection secondary to travel outside of the patients’ country of residence (Table 3) which included 11 countries; Germany (7) [53]-[59], Netherlands (5) [60]-[64], France (5) [65]-[69] Australia (3) [70]-[72], USA (4) [73]-[77], Israel (1), Canada (1) [78], Norway (1) [79], Italy (1) [80], Japan (1) [81], and Sweden (1) [82]. Leading exposure countries were from South East Asian region, including Thailand, Malaysia and Philippines which accounted for more than 1/3rd of cases. All case reports and case series were from high income countries.
Table 3
Case reports and case series on travel related leptospirosis
Reference
Country
Country of exposure
Region/City
Disease confirmation
Walter et al., [54],
Germany
Canada
  
Grobusch et al., [53]
Germany
Dominican Republic
Playa Dorada, Santiago/Los Ciruelitos, Santa Domingo, Juan Dolio, Mao
ELISA
Teichmann et al., [59]
Germany
Philippines
 
MAT
Green and Busuttil, [58]
Germany
Sardinia
  
Bernasconi et al., [57]
Germany
Switzerland
Southern
 
Steffens et al., [56]
Germany
Thailand
 
Serology, PCR
Seilmaier and Guggemos [55]
Germany
Thailand and Laos
 
Serology
Gelman et al., [73]
USA
Ecuador, Costa Rica
 
Culture, Dark field microscopy
Duplessis et al., [51]
USA
Hawaii
Maunuwili falls
 
Pashkow et al., [75]
USA
Honduras
  
Haake et al., [76]
USA
Malaysia
Sabah
Dip-S-Ticks, PanBio ELISA, Culture
Mortimer [74]
USA
Malaysia
Sarawak
 
Coursin et al., [52]
USA
USA
Hawaii
MAT
Monsuez et al., [67]
France
Africa
Cote d’Ivoire (Ivory Coast)
ELISA
Perret et al., [68]
France
Gabon
 
IgM
Jaureguiberry et al., [66]
France
Ivory Coast - 1, China - 1
 
ELISA, MAT
Simon et al., [69]
France
Mauritius Island
 
ELISA, MAT, PCR
Arzouni et al., [65]
France
Portugal and Spain
 
Dark field microscopy, PCR, Western blot, Culture
Maldonado et al., [64]
Netherlands
China
 
MAT
Arcilla et al., [60]
Netherlands
Dominican Republic
Altos de Chavón
MAT, ELISA, PCR
Wagenaar et al., [63]
Netherlands
Malaysia
Langkawi island
ELISA, MAT
Helmerhorst et al., [61]
Netherlands
Thailand
Bangkok and the North of Thailand
MAT
Kager et al., [62]
Netherlands
Thailand
 
Serology Culture
Heron et al., [70]
Australia
Africa, Ghana
Ghana
 
Gill et al., [71]
Australia
Fiji
 
ELISA (IgM)
Korman et al., [72]
Australia
Indonesia
Kalimantan
MAT, Culture, Dark field microscopy
Hadad et al., [32]
Israel
Israel
Jordan river (Nothern Israel)
MAT
Paz et al., [77]
Israel
Thailand, Cambodia
Kochang island, Thailand
MAT
Leung et al., [78]
Canada
Malaysia
Northeastern Malaysia
ELISA, MAT
Lagi et al., [80]
Australia
Italy
Venice
PCR, MAT
Sakamoto et al., [81]
Japan
Indonesia
Bali island
Dark field microscopy, MAT
Myrstad et al., [79]
Norway
France
Southern France
IgM, IgG
Guron et al., [82]
Sweden
Thailand
 
Serology

Discussion

The results from this review suggest a dynamic shift in the epidemiology of leptospirosis transmission due to increased human travel and migration on a global scale. While previous studies have offered insight into intra-national and intra-regional transmission, few have analyzed transmission across international borders. The results presented here suggest that secondary transmission of leptospirosis via human travel and migration across national borders is re-shaping the landscape of disease incidence and prevalence worldwide. Alongside regional environmental and occupational exposure, international travel now constitutes a major independent risk factor for disease acquisition.
Despite increases in travel-associated disease, the overall contribution of diagnosed leptospirosis to cases of febrile illness in returning travelers is still quite low (2.4%) [45]. This discrepancy is likely due to the lack of clinical suspicion among home-country clinicians as leptospirosis is rarely included in the differential diagnosis outside of endemic regions. Additional obstacles to diagnosis include the lack of home-country diagnostic facilities and general diagnostic inaccuracy due to serovar diversity between geographic regions. Countries having the highest number of cases detected in travelers returning from endemic regions (United States, Netherlands, Japan, France, Germany and Australia) are also equipped with highly developed reference laboratories, diagnostic capacity and research facilities. Such capacities may be limited in developing countries where tourist travel to endemic countries is equally common, ultimately leading to poor case detection and reporting bias.
In an era of globalization with increased global travel and migration, diseases that were thought to be isolated to tropical regions or affecting marginalized communities can no longer be considered as ‘tightly contained’ static entities [5]. It is imperative to view new international trends in transmission as a direct outgrowth of globalization. Such diseases are not emerging threats, but rather have been threats all along. Confined to mostly impoverished fishing and rice farming communities, Leptospirosis has for many decades gone largely undetected and neglected. The disease has also been a leading cause of morbidity and mortality in such communities for generations. Although Leptospirosis remains the most widespread zoonotic disease in the world, the greatest burden of the disease still remains with such marginalized communities. They face daily occupational exposure risks in order to earn their livelihoods. The new trends in global transmission stands as an important reminder that it is essential to design and implement a rigorous disease detection, prevention and treatment plan starting first at the community level.
Due to the complexity of the disease transmission, primary prevention of leptospirosis is difficult. In low and middle income tropical countries, the ecological system provides a conducive environment for leptospirosis transmission. Identification of local ‘hot spots’ of leptospirosis may help facilitate preventive activities. Public health authorities in endemic areas should coordinate with regional level authorities to compile and monitor epidemiological trends with the goal of actively identifying geographical areas which would benefit from increased service provision and education. If these hot spots correspond with mass gatherings or tourist attractions, then application of targeted primary and secondary preventive measures may become more feasible. As an example, recent reports of internal travel associated leptospirosis occured in Sri Lanka, in a place where white color workers were engaged in water sport [83]. Interventions were needed to target those involved in organizing recreational travel packages for white-water rafting in such settings. Strategies may also include participant education and chemoprophylaxis to prevent leptospirosis in those registering for such activities. Recent increase in leptospirosis among people engaged in water sports also pose the question of whether chemoprophylaxis should be taken as a routine practice. Since the evidence to support the use of chemoprophylaxis is still poor, more studies are needed to inform decision making [84].
The results of this review highlight the urgent need for developing travel guidelines and preventive strategies of leptospirosis related to travel. Awareness of leptospirosis among health professionals practicing in high-income countries where the disease seems exotic is essential for proper diagnosis and treatment. Further, stake holders such as tour companies, adventure sport organizers should also receive adequate knowledge on the increasing risk of leptospirosis.
Further research is needed to investigate the impact of occupational migration and forced displacement on leptospirosis prevalence and disease distribution. Given that migrant workers and refugees are often the most marginalized and underserved communities, detection, treatment and prevention of leptospirosis among this high-risk cohort has been largely ignored to date. Lastly additional studies are needed to assess the efficacy of long-term chemoprophylaxis with doxycycline and to identify other alternative less toxic agents for long-term use in high-risk groups.
We undertook our literature review using PubMed as the main electronic database with hand-searches of selected bibliographies to identify additional relevant literatures. This may not have captured an exhaustive list of literature. We did not analyze the disease transmission risk associated with the total length of time traveling, exposure history, route of transmission, visits to multiple regions in succession, occupation and clinical presentation stand as possible confounding variables which should be done in future studies.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.
The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
The Creative Commons Public Domain Dedication waiver (https://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Competing interests

All authors declare (1) no support from any organization for the submitted work; (2) no financial relationships with any organizations that might have an interest in the submitted work in the previous three years; and (3) no other relationships or activities that could appear to have influenced the submitted work.

Authors’ contribution

MB and MA carried out the literature search, data extraction and table preparation. MB and EB analyzed and interpreted data and prepared the draft manuscript. EB completed the manuscript writing. KW and SA conceived the study, design the methodology, revised the final manuscript and coordinated the review process. All authors read and approved the final manuscript.
Anhänge

Authors’ original submitted files for images

Below are the links to the authors’ original submitted files for images.
Literatur
1.
Zurück zum Zitat Bharti AR, Nally JE, Ricaldi JN, Matthias MA, Diaz MM, Lovett MA, Levett PN, Gilman RH, Willig MR, Gotuzzo E, Vinetz JM: Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis. 2003, 3: 757-771.PubMedCrossRef Bharti AR, Nally JE, Ricaldi JN, Matthias MA, Diaz MM, Lovett MA, Levett PN, Gilman RH, Willig MR, Gotuzzo E, Vinetz JM: Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis. 2003, 3: 757-771.PubMedCrossRef
2.
Zurück zum Zitat Murhekar MV, Sugunan AP, Vijayachari P, Sharma S, Sehgal SC: Risk factors in the transmission of leptospiral infection. Indian J Med Res. 1998, 107: 218-223.PubMed Murhekar MV, Sugunan AP, Vijayachari P, Sharma S, Sehgal SC: Risk factors in the transmission of leptospiral infection. Indian J Med Res. 1998, 107: 218-223.PubMed
3.
Zurück zum Zitat Abela-Ridder B, Sikkema R, Hartskeerl RA: Estimating the burden of human leptospirosis. Int J Antimicrob Agents. 2010, 36 (Suppl 1): S5-7.PubMedCrossRef Abela-Ridder B, Sikkema R, Hartskeerl RA: Estimating the burden of human leptospirosis. Int J Antimicrob Agents. 2010, 36 (Suppl 1): S5-7.PubMedCrossRef
4.
Zurück zum Zitat Abela-Ridder B, Bertherat E, Durski K: Global burden of Human Leptospirosis and cross-sectoral interventions for its prevention and control. Prince Mahidol Award Conference 2013. 2013, Prince Mahidol Award Conference, Bangkok, Thailand Abela-Ridder B, Bertherat E, Durski K: Global burden of Human Leptospirosis and cross-sectoral interventions for its prevention and control. Prince Mahidol Award Conference 2013. 2013, Prince Mahidol Award Conference, Bangkok, Thailand
5.
Zurück zum Zitat Pappas G, Papadimitriou P, Siozopoulou V, Christou L, Akritidis N: The globalization of leptospirosis: worldwide incidence trends. Int J Infect Dis. 2008, 12: 351-357.PubMedCrossRef Pappas G, Papadimitriou P, Siozopoulou V, Christou L, Akritidis N: The globalization of leptospirosis: worldwide incidence trends. Int J Infect Dis. 2008, 12: 351-357.PubMedCrossRef
6.
Zurück zum Zitat Monahan AM, Miller IS, Nally JE: Leptospirosis: risks during recreational activities. J Appl Microbiol. 2009, 107: 707-716.PubMedCrossRef Monahan AM, Miller IS, Nally JE: Leptospirosis: risks during recreational activities. J Appl Microbiol. 2009, 107: 707-716.PubMedCrossRef
8.
Zurück zum Zitat Sethi S, Sharma N, Kakkar N, Taneja J, Chatterjee SS, Banga SS, Sharma M: Increasing trends of leptospirosis in northern India: a clinico-epidemiological study. PLoS Negl Trop Dis. 2010, 4: e579.PubMedPubMedCentralCrossRef Sethi S, Sharma N, Kakkar N, Taneja J, Chatterjee SS, Banga SS, Sharma M: Increasing trends of leptospirosis in northern India: a clinico-epidemiological study. PLoS Negl Trop Dis. 2010, 4: e579.PubMedPubMedCentralCrossRef
9.
Zurück zum Zitat Picardeau M, Bertherat E, Jancloes M, Skouloudis AN, Durski K, Hartskeerl RA: Rapid tests for diagnosis of leptospirosis: current tools and emerging technologies. Diagn Microbiol Infect Dis. 2014, 78: 1-8.PubMedCrossRef Picardeau M, Bertherat E, Jancloes M, Skouloudis AN, Durski K, Hartskeerl RA: Rapid tests for diagnosis of leptospirosis: current tools and emerging technologies. Diagn Microbiol Infect Dis. 2014, 78: 1-8.PubMedCrossRef
10.
Zurück zum Zitat Reis RB, Ribeiro GS, Felzemburgh RD, Santana FS, Mohr S, Melendez AX, Queiroz A, Santos AC, Ravines RR, Tassinari WS, Carvalho MS, Reis MG, Ko AI: Impact of environment and social gradient on leptospira infection in urban slums. PLoS Negl Trop Dis. 2008, 2: e228.PubMedPubMedCentralCrossRef Reis RB, Ribeiro GS, Felzemburgh RD, Santana FS, Mohr S, Melendez AX, Queiroz A, Santos AC, Ravines RR, Tassinari WS, Carvalho MS, Reis MG, Ko AI: Impact of environment and social gradient on leptospira infection in urban slums. PLoS Negl Trop Dis. 2008, 2: e228.PubMedPubMedCentralCrossRef
11.
Zurück zum Zitat Karande S, Gandhi D, Kulkarni M, Bharadwaj R, Pol S, Thakare J, De A: Concurrent outbreak of leptospirosis and dengue in Mumbai, India, 2002. J Trop Pediatr. 2005, 51: 174-181.PubMedCrossRef Karande S, Gandhi D, Kulkarni M, Bharadwaj R, Pol S, Thakare J, De A: Concurrent outbreak of leptospirosis and dengue in Mumbai, India, 2002. J Trop Pediatr. 2005, 51: 174-181.PubMedCrossRef
12.
Zurück zum Zitat Kaur IR, Sachdeva R, Arora V, Talwar V: Preliminary survey of leptospirosis amongst febrile patients from urban slums of East Delhi. J Assoc Physicians India. 2003, 51: 249-251.PubMed Kaur IR, Sachdeva R, Arora V, Talwar V: Preliminary survey of leptospirosis amongst febrile patients from urban slums of East Delhi. J Assoc Physicians India. 2003, 51: 249-251.PubMed
13.
Zurück zum Zitat de Figueiredo CM, Mourao AC, de Oliveira MA, Alves WR, Ooteman MC, Chamone CB, Koury MC: Human leptospirosis in Belo Horizonte City, Minas Gerais, Brazil: a geographic approach. Rev Soc Bras Med Trop. 2001, 34: 331-338.PubMed de Figueiredo CM, Mourao AC, de Oliveira MA, Alves WR, Ooteman MC, Chamone CB, Koury MC: Human leptospirosis in Belo Horizonte City, Minas Gerais, Brazil: a geographic approach. Rev Soc Bras Med Trop. 2001, 34: 331-338.PubMed
14.
Zurück zum Zitat Ganoza CA, Matthias MA, Collins-Richards D, Brouwer KC, Cunningham CB, Segura ER, Gilman RH, Gotuzzo E, Vinetz JM: Determining risk for severe leptospirosis by molecular analysis of environmental surface waters for pathogenic Leptospira. PLoS Med. 2006, 3: e308.PubMedPubMedCentralCrossRef Ganoza CA, Matthias MA, Collins-Richards D, Brouwer KC, Cunningham CB, Segura ER, Gilman RH, Gotuzzo E, Vinetz JM: Determining risk for severe leptospirosis by molecular analysis of environmental surface waters for pathogenic Leptospira. PLoS Med. 2006, 3: e308.PubMedPubMedCentralCrossRef
15.
Zurück zum Zitat Johnson MA, Smith H, Joeph P, Gilman RH, Bautista CT, Campos KJ, Cespedes M, Klatsky P, Vidal C, Terry H, Calderon MM, Coral C, Cabrera L, Parmar PS, Vinetz JM: Environmental exposure and leptospirosis, Peru. Emerg Infect Dis. 2004, 10: 1016-1022.PubMedPubMedCentralCrossRef Johnson MA, Smith H, Joeph P, Gilman RH, Bautista CT, Campos KJ, Cespedes M, Klatsky P, Vidal C, Terry H, Calderon MM, Coral C, Cabrera L, Parmar PS, Vinetz JM: Environmental exposure and leptospirosis, Peru. Emerg Infect Dis. 2004, 10: 1016-1022.PubMedPubMedCentralCrossRef
16.
Zurück zum Zitat Ivanova S, Herbreteau V, Blasdell K, Chaval Y, Buchy P, Guillard B, Morand S: Leptospira and rodents in Cambodia: environmental determinants of infection. Am J Trop Med Hyg. 2012, 86: 1032-1038.PubMedPubMedCentralCrossRef Ivanova S, Herbreteau V, Blasdell K, Chaval Y, Buchy P, Guillard B, Morand S: Leptospira and rodents in Cambodia: environmental determinants of infection. Am J Trop Med Hyg. 2012, 86: 1032-1038.PubMedPubMedCentralCrossRef
17.
Zurück zum Zitat Gamage CD, Amarasekera J, Palihawadana P, Samaraweera S, Mendis D, Janakan N, Lee RB, Obayashi Y, Tamashiro H: Analysis of hospital-based sentinel surveillance data on leptospirosis in Sri Lanka, 2005–2008. Jpn J Infect Dis. 2012, 65: 157-161.PubMed Gamage CD, Amarasekera J, Palihawadana P, Samaraweera S, Mendis D, Janakan N, Lee RB, Obayashi Y, Tamashiro H: Analysis of hospital-based sentinel surveillance data on leptospirosis in Sri Lanka, 2005–2008. Jpn J Infect Dis. 2012, 65: 157-161.PubMed
18.
Zurück zum Zitat Padre LP, Watt G, Tuazon ML, Gray MR, Laughlin LW: A serologic survey of rice-field leptospirosis in Central Luzon, Philippines. Southeast Asian J Trop Med Public Health. 1988, 19: 197-199.PubMed Padre LP, Watt G, Tuazon ML, Gray MR, Laughlin LW: A serologic survey of rice-field leptospirosis in Central Luzon, Philippines. Southeast Asian J Trop Med Public Health. 1988, 19: 197-199.PubMed
19.
Zurück zum Zitat Everard CO, Hayes RJ, Fraser-Chanpong GM: A serosurvey for leptospirosis in Trinidad among urban and rural dwellers and persons occupationally at risk. Trans R Soc Trop Med Hyg. 1985, 79: 96-105.PubMedCrossRef Everard CO, Hayes RJ, Fraser-Chanpong GM: A serosurvey for leptospirosis in Trinidad among urban and rural dwellers and persons occupationally at risk. Trans R Soc Trop Med Hyg. 1985, 79: 96-105.PubMedCrossRef
20.
Zurück zum Zitat Agampodi SB, Peacock SJ, Thevanesam V, Nugegoda DB, Smythe L, Thaipadungpanit J, Craig SB, Burns MA, Dohnt M, Boonsilp S, Senaratne T, Kumara A, Palihawadana P, Perera S, Vinetz JM: Leptospirosis outbreak in Sri Lanka in 2008: lessons for assessing the global burden of disease. Am J Trop Med Hyg. 2011, 85: 471-478.PubMedPubMedCentralCrossRef Agampodi SB, Peacock SJ, Thevanesam V, Nugegoda DB, Smythe L, Thaipadungpanit J, Craig SB, Burns MA, Dohnt M, Boonsilp S, Senaratne T, Kumara A, Palihawadana P, Perera S, Vinetz JM: Leptospirosis outbreak in Sri Lanka in 2008: lessons for assessing the global burden of disease. Am J Trop Med Hyg. 2011, 85: 471-478.PubMedPubMedCentralCrossRef
21.
Zurück zum Zitat Suarez Hernandez M, Martinez Sanchez R, Posada Fernandez PE, Vidal Garcia I, Bravo Fleites F, Sanchez Sibello A: Human leptospirosis outbreak in the district of Ciego de Avila, Cuba. Rev Soc Bras Med Trop. 1999, 32: 13-18.PubMed Suarez Hernandez M, Martinez Sanchez R, Posada Fernandez PE, Vidal Garcia I, Bravo Fleites F, Sanchez Sibello A: Human leptospirosis outbreak in the district of Ciego de Avila, Cuba. Rev Soc Bras Med Trop. 1999, 32: 13-18.PubMed
22.
Zurück zum Zitat Mollaret HH, Mailloux M, Debarbat F: Leptospirosis on the Island of Reunion. III. Epidemiologic study. Bull Soc Pathol Exot Filiales. 1983, 76: 744-749.PubMed Mollaret HH, Mailloux M, Debarbat F: Leptospirosis on the Island of Reunion. III. Epidemiologic study. Bull Soc Pathol Exot Filiales. 1983, 76: 744-749.PubMed
23.
Zurück zum Zitat Ginebra Gonzalez O: Leptospirosis. Serological study of an epidemic outbrake in the province of Camaguey. Rev Cubana Med Trop. 1976, 28: 33-38.PubMed Ginebra Gonzalez O: Leptospirosis. Serological study of an epidemic outbrake in the province of Camaguey. Rev Cubana Med Trop. 1976, 28: 33-38.PubMed
24.
Zurück zum Zitat Bourquin V, Ponte B, Hirschel B, Pugin J, Martin PY, Saudan P: Severe leptospirosis with multiple organ failure successfully treated by plasma exchange and high-volume hemofiltration. Case Rep Nephrol. 2011, 2011: 817414.PubMedPubMedCentral Bourquin V, Ponte B, Hirschel B, Pugin J, Martin PY, Saudan P: Severe leptospirosis with multiple organ failure successfully treated by plasma exchange and high-volume hemofiltration. Case Rep Nephrol. 2011, 2011: 817414.PubMedPubMedCentral
25.
Zurück zum Zitat Herrero-Martinez JM, Fernandez-Ruiz M, Neil Hermenegildo Y, Gil H: [Leptospirosis in a sewer worker in Madrid: the role of molecular diagnosis]. Rev Clin Esp. 2012, 212: 554-555.PubMedCrossRef Herrero-Martinez JM, Fernandez-Ruiz M, Neil Hermenegildo Y, Gil H: [Leptospirosis in a sewer worker in Madrid: the role of molecular diagnosis]. Rev Clin Esp. 2012, 212: 554-555.PubMedCrossRef
26.
Zurück zum Zitat McLean M, Ruscoe Q, Kline T, King C, Nesdale A: A cluster of three cases of leptospirosis in dairy farm workers in New Zealand. N Z Med J. 2014, 127: 13-20.PubMed McLean M, Ruscoe Q, Kline T, King C, Nesdale A: A cluster of three cases of leptospirosis in dairy farm workers in New Zealand. N Z Med J. 2014, 127: 13-20.PubMed
27.
Zurück zum Zitat Molineri A, Signorini ML, Perez L, Tarabla HD: Zoonoses in rural veterinarians in the central region of Argentina. Aust J Rural Health. 2013, 21: 285-290.PubMedCrossRef Molineri A, Signorini ML, Perez L, Tarabla HD: Zoonoses in rural veterinarians in the central region of Argentina. Aust J Rural Health. 2013, 21: 285-290.PubMedCrossRef
28.
Zurück zum Zitat Bertherat E, Mueller MJ, Shako JC, Picardeau M: Discovery of a leptospirosis cluster amidst a pneumonic plague outbreak in a miners’ camp in the Democratic Republic of the Congo. Int J Environ Res Public Health. 2014, 11: 1824-1833.PubMedPubMedCentralCrossRef Bertherat E, Mueller MJ, Shako JC, Picardeau M: Discovery of a leptospirosis cluster amidst a pneumonic plague outbreak in a miners’ camp in the Democratic Republic of the Congo. Int J Environ Res Public Health. 2014, 11: 1824-1833.PubMedPubMedCentralCrossRef
29.
Zurück zum Zitat Poeppl W, Orola MJ, Herkner H, Muller M, Tobudic S, Faas A, Mooseder G, Allerberger F, Burgmann H: High prevalence of antibodies against Leptospira spp. in male Austrian adults: a cross-sectional survey, April to June 2009.Euro Surveill 2013, 18:. Poeppl W, Orola MJ, Herkner H, Muller M, Tobudic S, Faas A, Mooseder G, Allerberger F, Burgmann H: High prevalence of antibodies against Leptospira spp. in male Austrian adults: a cross-sectional survey, April to June 2009.Euro Surveill 2013, 18:.
30.
Zurück zum Zitat Lupi O, Netto MA, Avelar K, Romero C, Bruniera R, Brasil P: Cluster of leptospirosis cases among military personnel in Rio de Janeiro, Brazil. Int J Infect Dis. 2013, 17: e129-131.PubMedCrossRef Lupi O, Netto MA, Avelar K, Romero C, Bruniera R, Brasil P: Cluster of leptospirosis cases among military personnel in Rio de Janeiro, Brazil. Int J Infect Dis. 2013, 17: e129-131.PubMedCrossRef
31.
Zurück zum Zitat Burns DS, Bailey MS: Undifferentiated febrile illnesses in military personnel. J R Army Med Corps. 2013, 159: 200-205.PubMedCrossRef Burns DS, Bailey MS: Undifferentiated febrile illnesses in military personnel. J R Army Med Corps. 2013, 159: 200-205.PubMedCrossRef
32.
Zurück zum Zitat Hadad E, Pirogovsky A, Bartal C, Gilad J, Barnea A, Yitzhaki S, Grotto I, Balicer RD, Schwartz E: An outbreak of leptospirosis among Israeli troops near the Jordan River. Am J Trop Med Hyg. 2006, 74: 127-131.PubMed Hadad E, Pirogovsky A, Bartal C, Gilad J, Barnea A, Yitzhaki S, Grotto I, Balicer RD, Schwartz E: An outbreak of leptospirosis among Israeli troops near the Jordan River. Am J Trop Med Hyg. 2006, 74: 127-131.PubMed
33.
Zurück zum Zitat Leptospirosis outbreak in Eco Challenge 2000 participants.Commun Dis Rep CDR Wkly 2000, 10:341. Leptospirosis outbreak in Eco Challenge 2000 participants.Commun Dis Rep CDR Wkly 2000, 10:341.
34.
Zurück zum Zitat Wasinski B, Dutkiewicz J: Leptospirosis–current risk factors connected with human activity and the environment. Ann Agric Environ Med. 2013, 20: 239-244.PubMed Wasinski B, Dutkiewicz J: Leptospirosis–current risk factors connected with human activity and the environment. Ann Agric Environ Med. 2013, 20: 239-244.PubMed
35.
Zurück zum Zitat Report of the second meeting of leptospirosis burden epidemiology reference group. Book Report of the second meeting of leptospirosis burden epidemiology reference group. 2011, 1-34. World Health Organization, City Report of the second meeting of leptospirosis burden epidemiology reference group. Book Report of the second meeting of leptospirosis burden epidemiology reference group. 2011, 1-34. World Health Organization, City
36.
Zurück zum Zitat Goris MG, Boer KR, Duarte TA, Kliffen SJ, Hartskeerl RA: Human leptospirosis trends, the Netherlands, 1925–2008. Emerg Infect Dis. 2013, 19: 371-378.PubMedPubMedCentralCrossRef Goris MG, Boer KR, Duarte TA, Kliffen SJ, Hartskeerl RA: Human leptospirosis trends, the Netherlands, 1925–2008. Emerg Infect Dis. 2013, 19: 371-378.PubMedPubMedCentralCrossRef
37.
Zurück zum Zitat van Crevel R, Speelman P, Gravekamp C, Terpstra WJ: Leptospirosis in travelers. Clin Infect Dis. 1994, 19: 132-134.PubMedCrossRef van Crevel R, Speelman P, Gravekamp C, Terpstra WJ: Leptospirosis in travelers. Clin Infect Dis. 1994, 19: 132-134.PubMedCrossRef
38.
Zurück zum Zitat Leshem E, Segal G, Barnea A, Yitzhaki S, Ostfeld I, Pitlik S, Schwartz E: Travel-related leptospirosis in Israel: a nationwide study. Am J Trop Med Hyg. 2010, 82: 459-463.PubMedPubMedCentralCrossRef Leshem E, Segal G, Barnea A, Yitzhaki S, Ostfeld I, Pitlik S, Schwartz E: Travel-related leptospirosis in Israel: a nationwide study. Am J Trop Med Hyg. 2010, 82: 459-463.PubMedPubMedCentralCrossRef
39.
Zurück zum Zitat Hoffmeister B, Peyerl-Hoffmann G, Pischke S, Zollner-Schwetz I, Krause R, Muller MC, Graf A, Kluge S, Burchard GD, Kern WV, Suttorp N, Cramer JP: Differences in clinical manifestations of imported versus autochthonous leptospirosis in Austria and Germany. Am J Trop Med Hyg. 2010, 83: 326-335.PubMedPubMedCentralCrossRef Hoffmeister B, Peyerl-Hoffmann G, Pischke S, Zollner-Schwetz I, Krause R, Muller MC, Graf A, Kluge S, Burchard GD, Kern WV, Suttorp N, Cramer JP: Differences in clinical manifestations of imported versus autochthonous leptospirosis in Austria and Germany. Am J Trop Med Hyg. 2010, 83: 326-335.PubMedPubMedCentralCrossRef
40.
41.
Zurück zum Zitat Narita M, Fujitani S, Haake DA, Paterson DL: Leptospirosis after recreational exposure to water in the Yaeyama islands, Japan. Am J Trop Med Hyg. 2005, 73: 652-656.PubMedPubMedCentral Narita M, Fujitani S, Haake DA, Paterson DL: Leptospirosis after recreational exposure to water in the Yaeyama islands, Japan. Am J Trop Med Hyg. 2005, 73: 652-656.PubMedPubMedCentral
42.
Zurück zum Zitat Taniguchi K, Yoshida M, Sunagawa T, Tada Y, Okabe N: Imported infectious diseases and surveillance in Japan. Travel Med Infect Dis. 2008, 6: 349-354.PubMedCrossRef Taniguchi K, Yoshida M, Sunagawa T, Tada Y, Okabe N: Imported infectious diseases and surveillance in Japan. Travel Med Infect Dis. 2008, 6: 349-354.PubMedCrossRef
43.
Zurück zum Zitat Ariyapruchya B, Sungkanuparph S, Dumrongkitchaiporn S: Clinical presentation and medical complication in 59 cases of laboratory-confirmed leptospirosis in Bangkok. Southeast Asian J Trop Med Public Health. 2003, 34: 159-164.PubMed Ariyapruchya B, Sungkanuparph S, Dumrongkitchaiporn S: Clinical presentation and medical complication in 59 cases of laboratory-confirmed leptospirosis in Bangkok. Southeast Asian J Trop Med Public Health. 2003, 34: 159-164.PubMed
44.
Zurück zum Zitat Katz AR, Ansdell VE, Effler PV, Middleton CR, Sasaki DM: Assessment of the clinical presentation and treatment of 353 cases of laboratory-confirmed leptospirosis in Hawaii, 1974–1998. Clin Infect Dis. 2001, 33: 1834-1841.PubMedCrossRef Katz AR, Ansdell VE, Effler PV, Middleton CR, Sasaki DM: Assessment of the clinical presentation and treatment of 353 cases of laboratory-confirmed leptospirosis in Hawaii, 1974–1998. Clin Infect Dis. 2001, 33: 1834-1841.PubMedCrossRef
45.
Zurück zum Zitat Jensenius M, Han PV, Schlagenhauf P, Schwartz E, Parola P, Castelli F, von Sonnenburg F, Loutan L, Leder K, Freedman DO: Acute and potentially life-threatening tropical diseases in western travelers–a GeoSentinel multicenter study, 1996–2011. Am J Trop Med Hyg. 2013, 88: 397-404.PubMedPubMedCentralCrossRef Jensenius M, Han PV, Schlagenhauf P, Schwartz E, Parola P, Castelli F, von Sonnenburg F, Loutan L, Leder K, Freedman DO: Acute and potentially life-threatening tropical diseases in western travelers–a GeoSentinel multicenter study, 1996–2011. Am J Trop Med Hyg. 2013, 88: 397-404.PubMedPubMedCentralCrossRef
46.
Zurück zum Zitat Askling HH, Lesko B, Vene S, Berndtson A, Bjorkman P, Blackberg J, Bronner U, Follin P, Hellgren U, Palmerus M, Ekdahl K, Tegnell A, Struwe J: Serologic analysis of returned travelers with fever, Sweden. Emerg Infect Dis. 2009, 15: 1805-1808.PubMedPubMedCentralCrossRef Askling HH, Lesko B, Vene S, Berndtson A, Bjorkman P, Blackberg J, Bronner U, Follin P, Hellgren U, Palmerus M, Ekdahl K, Tegnell A, Struwe J: Serologic analysis of returned travelers with fever, Sweden. Emerg Infect Dis. 2009, 15: 1805-1808.PubMedPubMedCentralCrossRef
47.
Zurück zum Zitat Goldsmid JM, Bettiol SS, Sharples N: A preliminary study on travel health issues of medical students undertaking electives. J Travel Med. 2003, 10: 160-163.PubMedCrossRef Goldsmid JM, Bettiol SS, Sharples N: A preliminary study on travel health issues of medical students undertaking electives. J Travel Med. 2003, 10: 160-163.PubMedCrossRef
48.
Zurück zum Zitat Siikamaki HM, Kivela PS, Sipila PN, Kettunen A, Kainulainen MK, Ollgren JP, Kantele A: Fever in travelers returning from malaria-endemic areas: don’t look for malaria only. J Travel Med. 2011, 18: 239-244.PubMedCrossRef Siikamaki HM, Kivela PS, Sipila PN, Kettunen A, Kainulainen MK, Ollgren JP, Kantele A: Fever in travelers returning from malaria-endemic areas: don’t look for malaria only. J Travel Med. 2011, 18: 239-244.PubMedCrossRef
49.
Zurück zum Zitat Flores-Figueroa J, Okhuysen PC, von Sonnenburg F, DuPont HL, Libman MD, Keystone JS, Hale DC, Burchard G, Han PV, Wilder-Smith A, Freedman DO: Patterns of illness in travelers visiting Mexico and Central America: the GeoSentinel experience. Clin Infect Dis. 2011, 53: 523-531.PubMedCrossRef Flores-Figueroa J, Okhuysen PC, von Sonnenburg F, DuPont HL, Libman MD, Keystone JS, Hale DC, Burchard G, Han PV, Wilder-Smith A, Freedman DO: Patterns of illness in travelers visiting Mexico and Central America: the GeoSentinel experience. Clin Infect Dis. 2011, 53: 523-531.PubMedCrossRef
50.
Zurück zum Zitat Field V, Gautret P, Schlagenhauf P, Burchard GD, Caumes E, Jensenius M, Castelli F, Gkrania-Klotsas E, Weld L, Lopez-Velez R, de Vries P, von Sonnenburg F, Loutan L, Parola P: Travel and migration associated infectious diseases morbidity in Europe, 2008. BMC Infect Dis. 2010, 10: 330.PubMedPubMedCentralCrossRef Field V, Gautret P, Schlagenhauf P, Burchard GD, Caumes E, Jensenius M, Castelli F, Gkrania-Klotsas E, Weld L, Lopez-Velez R, de Vries P, von Sonnenburg F, Loutan L, Parola P: Travel and migration associated infectious diseases morbidity in Europe, 2008. BMC Infect Dis. 2010, 10: 330.PubMedPubMedCentralCrossRef
51.
Zurück zum Zitat Duplessis CA, Sklar MJ, Maves RC, Spichler A, Hale B, Johnson M, Bavaro M, Vinetz JM: Hemoptysis associated with leptospirosis acquired in Hawaii, USA. Emerg Infect Dis. 2011, 17: 2375-2377.PubMedPubMedCentralCrossRef Duplessis CA, Sklar MJ, Maves RC, Spichler A, Hale B, Johnson M, Bavaro M, Vinetz JM: Hemoptysis associated with leptospirosis acquired in Hawaii, USA. Emerg Infect Dis. 2011, 17: 2375-2377.PubMedPubMedCentralCrossRef
52.
Zurück zum Zitat Coursin DB, Updike SJ, Maki DG: Massive rhabdomyolysis and multiple organ dysfunction syndrome caused by leptospirosis. Intensive Care Med. 2000, 26: 808-812.PubMedCrossRef Coursin DB, Updike SJ, Maki DG: Massive rhabdomyolysis and multiple organ dysfunction syndrome caused by leptospirosis. Intensive Care Med. 2000, 26: 808-812.PubMedCrossRef
53.
Zurück zum Zitat Grobusch MP, Bollmann R, Schonberg A, Slevogt H, Garcia V, Teichmann D, Jelinek T, Flick H, Bergmann F, Rosseau S, Temmesfeld-Wollbrück B, Suttorp N: Leptospirosis in travelers returning from the Dominican Republic. J Travel Med. 2003, 10: 55-58.PubMedCrossRef Grobusch MP, Bollmann R, Schonberg A, Slevogt H, Garcia V, Teichmann D, Jelinek T, Flick H, Bergmann F, Rosseau S, Temmesfeld-Wollbrück B, Suttorp N: Leptospirosis in travelers returning from the Dominican Republic. J Travel Med. 2003, 10: 55-58.PubMedCrossRef
54.
Zurück zum Zitat Walter B, Wein B, Bittinger M, Messmann H: [Leptospirosis (Weil’s disease) in Augsburg]. Dtsch Med Wochenschr. 2010, 135: 675-678.PubMedCrossRef Walter B, Wein B, Bittinger M, Messmann H: [Leptospirosis (Weil’s disease) in Augsburg]. Dtsch Med Wochenschr. 2010, 135: 675-678.PubMedCrossRef
55.
Zurück zum Zitat Seilmaier M, Guggemos W: [Severe febrile illness with renal impairment after travel to Southeast Asia]. Internist (Berl). 2008, 49: 1372, 1374-1376, 1378.CrossRef Seilmaier M, Guggemos W: [Severe febrile illness with renal impairment after travel to Southeast Asia]. Internist (Berl). 2008, 49: 1372, 1374-1376, 1378.CrossRef
56.
Zurück zum Zitat Steffens F, Landwehrs A, Goke MN: [Leptospirosis after a stay in Thailand]. Dtsch Med Wochenschr. 2006, 131: 1521-1524.PubMedCrossRef Steffens F, Landwehrs A, Goke MN: [Leptospirosis after a stay in Thailand]. Dtsch Med Wochenschr. 2006, 131: 1521-1524.PubMedCrossRef
57.
Zurück zum Zitat Bernasconi E, Gayer R, Busolini E, Mombelli G: [Endemic and imported severe leptospirosis (Weil’s disease) in southern Switzerland]. Schweiz Med Wochenschr. 2000, 130: 1487-1492.PubMed Bernasconi E, Gayer R, Busolini E, Mombelli G: [Endemic and imported severe leptospirosis (Weil’s disease) in southern Switzerland]. Schweiz Med Wochenschr. 2000, 130: 1487-1492.PubMed
58.
59.
Zurück zum Zitat Teichmann D, Gobels K, Simon J, Grobusch MP, Suttorp N: A severe case of leptospirosis acquired during an iron man contest. Eur J Clin Microbiol Infect Dis. 2001, 20: 137-138.PubMed Teichmann D, Gobels K, Simon J, Grobusch MP, Suttorp N: A severe case of leptospirosis acquired during an iron man contest. Eur J Clin Microbiol Infect Dis. 2001, 20: 137-138.PubMed
60.
Zurück zum Zitat Arcilla M, Wismans PJ, van Beek-Nieuwland Y, van Genderen PJ: Severe leptospirosis in a Dutch traveller returning from the Dominican Republic, October 2011.Euro Surveill 2012, 17 Arcilla M, Wismans PJ, van Beek-Nieuwland Y, van Genderen PJ: Severe leptospirosis in a Dutch traveller returning from the Dominican Republic, October 2011.Euro Surveill 2012, 17
61.
Zurück zum Zitat Helmerhorst HJ, van Tol EN, Tuinman PR, de Vries PJ, Hartskeerl RA, Grobusch MP, Hovius JW: Severe pulmonary manifestation of leptospirosis. Neth J Med. 2012, 70: 215-221.PubMed Helmerhorst HJ, van Tol EN, Tuinman PR, de Vries PJ, Hartskeerl RA, Grobusch MP, Hovius JW: Severe pulmonary manifestation of leptospirosis. Neth J Med. 2012, 70: 215-221.PubMed
62.
Zurück zum Zitat Kager PA, van Gorp EC, van Thiel PP: Fever and chills due to leptospirosis after travel to Thailand. Ned Tijdschr Geneeskd. 2001, 145: 184-186.PubMed Kager PA, van Gorp EC, van Thiel PP: Fever and chills due to leptospirosis after travel to Thailand. Ned Tijdschr Geneeskd. 2001, 145: 184-186.PubMed
63.
Zurück zum Zitat Wagenaar JF, de Vries PJ, Hartskeerl RA: Leptospirosis with pulmonary hemorrhage, caused by a new strain of serovar Lai: Langkawi. J Travel Med. 2004, 11: 379-381.PubMedCrossRef Wagenaar JF, de Vries PJ, Hartskeerl RA: Leptospirosis with pulmonary hemorrhage, caused by a new strain of serovar Lai: Langkawi. J Travel Med. 2004, 11: 379-381.PubMedCrossRef
64.
Zurück zum Zitat Maldonado F, Portier H, Kisterman JP: Bilateral facial palsy in a case of leptospirosis. Scand J Infect Dis. 2004, 36: 386-388.PubMedCrossRef Maldonado F, Portier H, Kisterman JP: Bilateral facial palsy in a case of leptospirosis. Scand J Infect Dis. 2004, 36: 386-388.PubMedCrossRef
65.
Zurück zum Zitat Arzouni JP, Parola P, La Scola B, Postic D, Brouqui P, Raoult D: Human infection caused by Leptospira fainei. Emerg Infect Dis. 2002, 8: 865-868.PubMedPubMedCentralCrossRef Arzouni JP, Parola P, La Scola B, Postic D, Brouqui P, Raoult D: Human infection caused by Leptospira fainei. Emerg Infect Dis. 2002, 8: 865-868.PubMedPubMedCentralCrossRef
66.
Zurück zum Zitat Jaureguiberry S, Roussel M, Brinchault-Rabin G, Gacouin A, Le Meur A, Arvieux C, Michelet C, Tattevin P: Clinical presentation of leptospirosis: a retrospective study of 34 patients admitted to a single institution in metropolitan France. Clin Microbiol Infect. 2005, 11: 391-394.PubMedCrossRef Jaureguiberry S, Roussel M, Brinchault-Rabin G, Gacouin A, Le Meur A, Arvieux C, Michelet C, Tattevin P: Clinical presentation of leptospirosis: a retrospective study of 34 patients admitted to a single institution in metropolitan France. Clin Microbiol Infect. 2005, 11: 391-394.PubMedCrossRef
67.
Zurück zum Zitat Monsuez JJ, Kidouche R, Le Gueno B, Postic D: Leptospirosis presenting as haemorrhagic fever in visitor to Africa. Lancet. 1997, 349: 254-255.PubMedCrossRef Monsuez JJ, Kidouche R, Le Gueno B, Postic D: Leptospirosis presenting as haemorrhagic fever in visitor to Africa. Lancet. 1997, 349: 254-255.PubMedCrossRef
68.
Zurück zum Zitat Perret JL, Velasque L, Morillon M, Martet G: [Leptospirosis: a cause of pseudo-malarial fever in Gabon]. Bull Soc Pathol Exot. 1996, 89: 217-219.PubMed Perret JL, Velasque L, Morillon M, Martet G: [Leptospirosis: a cause of pseudo-malarial fever in Gabon]. Bull Soc Pathol Exot. 1996, 89: 217-219.PubMed
69.
Zurück zum Zitat Simon F, Morand G, Roche C, Coton T, Kraemer P, Fournier PE, Gautret P: Leptospirosis in a French traveler returning from Mauritius. J Travel Med. 2012, 19: 69-71.PubMedCrossRef Simon F, Morand G, Roche C, Coton T, Kraemer P, Fournier PE, Gautret P: Leptospirosis in a French traveler returning from Mauritius. J Travel Med. 2012, 19: 69-71.PubMedCrossRef
70.
Zurück zum Zitat Heron LG, Reiss-Levy EA, Jacques TC, Dickeson DJ, Smythe LD, Sorrell TC: Leptospirosis presenting as a haemorrhagic fever in a traveller from Africa. Med J Aust. 1997, 167: 477-479.PubMed Heron LG, Reiss-Levy EA, Jacques TC, Dickeson DJ, Smythe LD, Sorrell TC: Leptospirosis presenting as a haemorrhagic fever in a traveller from Africa. Med J Aust. 1997, 167: 477-479.PubMed
71.
Zurück zum Zitat Gill AC, Allen H, Campbell D: Fever in a teenage traveller. J Paediatr Child Health. 2002, 38: 610-611.PubMedCrossRef Gill AC, Allen H, Campbell D: Fever in a teenage traveller. J Paediatr Child Health. 2002, 38: 610-611.PubMedCrossRef
72.
Zurück zum Zitat Korman TM, Globan MS, Smythe LD, Street AC: Leptospirosis in a returned traveller: isolation of a new Leptospira serovar. Aust N Z J Med. 1997, 27: 716-717.PubMedCrossRef Korman TM, Globan MS, Smythe LD, Street AC: Leptospirosis in a returned traveller: isolation of a new Leptospira serovar. Aust N Z J Med. 1997, 27: 716-717.PubMedCrossRef
73.
Zurück zum Zitat Gelman SS, Gundlapalli AV, Hale D, Croft A, Hindiyeh M, Carroll KC: Spotting the spirochete: rapid diagnosis of leptospirosis in two returned travelers. J Travel Med. 2002, 9: 165-167.PubMedCrossRef Gelman SS, Gundlapalli AV, Hale D, Croft A, Hindiyeh M, Carroll KC: Spotting the spirochete: rapid diagnosis of leptospirosis in two returned travelers. J Travel Med. 2002, 9: 165-167.PubMedCrossRef
74.
Zurück zum Zitat Mortimer RB: Leptospirosis in a caver returned from Sarawak, Malaysia. Wilderness Environ Med. 2005, 16: 129-131.PubMedCrossRef Mortimer RB: Leptospirosis in a caver returned from Sarawak, Malaysia. Wilderness Environ Med. 2005, 16: 129-131.PubMedCrossRef
75.
Zurück zum Zitat Pashkow FJ, Calisher CH, Reller LB, Sulzer CR: Leptospirosis in a traveler from Honduras. Colo Med. 1981, 78: 210-212.PubMed Pashkow FJ, Calisher CH, Reller LB, Sulzer CR: Leptospirosis in a traveler from Honduras. Colo Med. 1981, 78: 210-212.PubMed
76.
Zurück zum Zitat Haake DA, Dundoo M, Cader R, Kubak BM, Hartskeerl RA, Sejvar JJ, Ashford DA: Leptospirosis, water sports, and chemoprophylaxis. Clin Infect Dis. 2002, 34: e40-43.PubMedPubMedCentralCrossRef Haake DA, Dundoo M, Cader R, Kubak BM, Hartskeerl RA, Sejvar JJ, Ashford DA: Leptospirosis, water sports, and chemoprophylaxis. Clin Infect Dis. 2002, 34: e40-43.PubMedPubMedCentralCrossRef
77.
Zurück zum Zitat Paz A, Krimerman S, Potasman I: Leptospirosis masquerading as infectious enteritis. Travel Med Infect Dis. 2004, 2: 89-91.PubMedCrossRef Paz A, Krimerman S, Potasman I: Leptospirosis masquerading as infectious enteritis. Travel Med Infect Dis. 2004, 2: 89-91.PubMedCrossRef
79.
Zurück zum Zitat Myrstad M, Tazmini K, Spaeren KH, Bucher A: A fit man with fever and pain in both thighs. Tidsskr Nor Laegeforen. 2012, 132: 668-670.PubMedCrossRef Myrstad M, Tazmini K, Spaeren KH, Bucher A: A fit man with fever and pain in both thighs. Tidsskr Nor Laegeforen. 2012, 132: 668-670.PubMedCrossRef
80.
Zurück zum Zitat Lagi F, Corti G, Meli M, Pinto A, Bartoloni A: Leptospirosis acquired by tourists in Venice, Italy. J Travel Med. 2013, 20: 128-130.PubMedCrossRef Lagi F, Corti G, Meli M, Pinto A, Bartoloni A: Leptospirosis acquired by tourists in Venice, Italy. J Travel Med. 2013, 20: 128-130.PubMedCrossRef
81.
Zurück zum Zitat Sakamoto M, Kato T, Sato F, Yoshikawa K, Yoshida M, Shiba K, Onodera S, Hoshina S, Koizumi N, Watanabe H: [A case of leptospirosis caused by Leptospira borgpetersenii serovar sejroe infected in Bali Island, Indonesia]. Kansenshogaku Zasshi. 2005, 79: 294-298.PubMedCrossRef Sakamoto M, Kato T, Sato F, Yoshikawa K, Yoshida M, Shiba K, Onodera S, Hoshina S, Koizumi N, Watanabe H: [A case of leptospirosis caused by Leptospira borgpetersenii serovar sejroe infected in Bali Island, Indonesia]. Kansenshogaku Zasshi. 2005, 79: 294-298.PubMedCrossRef
82.
Zurück zum Zitat Guron G, Holmdahl J, Dotevall L: Acute renal failure after a holiday in the tropics. Clin Nephrol. 2006, 66: 468-471.PubMedCrossRef Guron G, Holmdahl J, Dotevall L: Acute renal failure after a holiday in the tropics. Clin Nephrol. 2006, 66: 468-471.PubMedCrossRef
83.
Zurück zum Zitat Agampodi SB, Karunarathna D, Jayathilala N, Rathnayaka H, Agampodi TC, Karunanayaka L: Outbreak of leptospirosis after white-water rafting: sign of a shift from rural to recreational leptospirosis in Sri Lanka?. Epidemiol Infect. 2014, 142: 843-846.PubMedCrossRef Agampodi SB, Karunarathna D, Jayathilala N, Rathnayaka H, Agampodi TC, Karunanayaka L: Outbreak of leptospirosis after white-water rafting: sign of a shift from rural to recreational leptospirosis in Sri Lanka?. Epidemiol Infect. 2014, 142: 843-846.PubMedCrossRef
84.
Zurück zum Zitat Brett-Major DM, Lipnick RJ: Antibiotic prophylaxis for leptospirosis. Cochrane Database Syst Rev. 2009, 3: CD007342.PubMed Brett-Major DM, Lipnick RJ: Antibiotic prophylaxis for leptospirosis. Cochrane Database Syst Rev. 2009, 3: CD007342.PubMed
Metadaten
Titel
Globalization of leptospirosis through travel and migration
Publikationsdatum
01.12.2014
Erschienen in
Globalization and Health / Ausgabe 1/2014
Elektronische ISSN: 1744-8603
DOI
https://doi.org/10.1186/s12992-014-0061-0

Weitere Artikel der Ausgabe 1/2014

Globalization and Health 1/2014 Zur Ausgabe